Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mahin Nikogoftar Zarif"'
Autor:
Reza Ranjbaran, Mahin Nikogoftar Zarif, Sedigheh Sharifzadeh, Habibollah Golafshan, Ali Akbar Pourfathollah
Publikováno v:
Cell Journal, Vol 20, Iss 3, Pp 318-325 (2018)
Objective Hemoglobin F (HbF) augmentation is considered a clinically beneficial phenomenon in β-hemoglobinopathies. Prevention of γ-globin gene silencing, inspired by the hereditary persistence of fetal hemoglobin, may be a suitable strategy to up
Externí odkaz:
https://doaj.org/article/c4b84e8d98404ce6819e1050cd42c429
Autor:
Saeed Mohammadi, Seyed H Ghaffari, Mojgan Shaiegan, Mahin Nikogoftar Zarif, Mohsen Nikbakht, Kamran Alimoghaddam, Ardeshir Ghavamzadeh
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 10, Iss 3 (2016)
Background: Acute myeloid leukemia (AML) is an immunophenotypically heterogeneous malignant disease, in which CD34 positivity is associated with poor prognosis. Osteopontin (OPN) plays different roles in physiologic and pathologic conditions like: su
Externí odkaz:
https://doaj.org/article/1ef4bbfe058f467dadcb69c8b571cafd
Autor:
Reza Ranjbaran, Mahin Nikogoftar Zarif, Sedigheh Sharifzadeh, Habibollah Golafshan, Ali Akbar Pourfathollah
Publikováno v:
Cell Journal (Yakhteh)
Cell Journal, Vol 20, Iss 3, Pp 318-325 (2018)
Cell Journal, Vol 20, Iss 3, Pp 318-325 (2018)
Objective Hemoglobin F (HbF) augmentation is considered a clinically beneficial phenomenon in β-hemoglobinopathies. Prevention of γ-globin gene silencing, inspired by the hereditary persistence of fetal hemoglobin, may be a suitable strategy to upr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::21ad37f41491ec0d2b32a668b714ea8f
https://pubmed.ncbi.nlm.nih.gov/29845784
https://pubmed.ncbi.nlm.nih.gov/29845784
Autor:
Tahereh Ali-Esfahani, Ali Akbar Pourfathollah, Jamileh Salar-Amoli, Ali Bashiri Dezfouli, Mina Yazdi, Mahin Nikogoftar-Zarif, Mohammad Khosravi
Publikováno v:
Medical Journal of the Islamic Republic of Iran
Background: Doxorubicin, by aggregating in bone marrow, causes genotoxic effects, and thus reduces the repair ability of cells. The present study was conducted as an in vitro evaluation of age effects on the cytotoxicity induced by doxorubicin in mes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d39d6c22ae50957ebfcbb3ad553e188
https://pubmed.ncbi.nlm.nih.gov/29951399
https://pubmed.ncbi.nlm.nih.gov/29951399
Autor:
Ranjbaran, Reza1,2, Zarif, Mahin Nikogoftar1, Sharifzadeh, Sedigheh2, Golafshan, Habibollah2, Pourfathollah, Ali Akbar1 ali.pourfa.ibto@gmail.com
Publikováno v:
Cell Journal (Yakhteh). Autumn2018, Vol. 20 Issue 3, p318-325. 8p.
Autor:
Mohammadi, Saeed1,2, Ghaffari, Seyed H.2, Shaiegan, Mojgan1 M.Shaiegan@ibto.ir, Zarif, Mahin Nikogoftar1, Nikbakht, Mohsen2, Alimoghaddam, Kamran2, Ghavamzadeh, Ardeshir2
Publikováno v:
International Journal of Hematology-Oncology & Stem Cell Research. 7/1/2016, Vol. 10 Issue 3, p120-129. 10p.